Announced Thu, 2 Apr · 13:28 IST

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the proceedings of the 01st Extra-Ordinary General Meeting ('EGM') ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹56.26
prior close
₹57.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+4.0+6.1+8.2+10.4+12.6+17.1+37.1+37.7+44.6+138.8
Up moveDown movePending
AI summary

Covidh Technologies Ltd held an Extra-Ordinary General Meeting on April 02, 2026, chaired by Managing Director Ms. Jayshree Suresh Jain, with 34 members attending. The meeting passed five resolutions: (1) a Special Resolution approving the change of company name from 'Covidh Technologies Limited' to 'iSERA Lifesciences Limited' along with consequential changes to MOA and AOA; (2-5) four Ordinary Resolutions appointing Mr Dhairyasheel Vasantrao Yadav and Mr Nandkumar Subhash Kadam as Executive Directors, and Mr Pratap Dadasaheb Deshmukh and Ms Ritu Dhanraj Garad as Non-Executive, Non-Independent Directors. All resolutions were passed with shareholder approval through remote e-voting and e-voting at the meeting.

Likely market impact

The name change to iSERA Lifesciences Limited signals a strategic pivot from technology to life sciences/pharma sector. The appointment of four new directors indicates a significant board restructuring that could bring new leadership direction to the company.